Association of Serum Uric Acid with Cardiovascular Disease in Taiwanese Patients with Primary Hypertension

被引:7
作者
Yang, Tsung-Yuan [1 ]
Fang, Chih-Yuan [2 ]
Chen, Jung-Sheng [3 ]
Po, Helen L. [4 ]
Chou, Li-Ping [5 ]
Chiang, Chih-Yeng [6 ]
Ueng, Kwo-Chang [1 ]
机构
[1] Chung Shan Med Univ, Chung Shan Med Univ Hosp, Dept Internal Med, Inst Med, Taichung 402, Taiwan
[2] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr, Kaohsiung, Taiwan
[3] Chu Shang Show Chwan Hosp, New Taipei City, Taiwan
[4] Mackay Mem Hosp, New Taipei City, Taiwan
[5] Sin Lau Hosp, Presbyterian Church Taiwan, New Taipei City, Taiwan
[6] Cardinal Tien Hosp, Yung Ho Branch, New Taipei City, Taiwan
关键词
Cardiovascular disease; Hypertension; Hyperuricemia; Uric acid; RISK-FACTOR; ENDOTHELIAL DYSFUNCTION; SCREENED COHORT; HYPERURICEMIA; URATE; PREDICTOR; MORTALITY; GLUCOSE; OKINAWA; EVENTS;
D O I
10.6515/ACS20140120A
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hyperuricemia is closely linked to hypertension and may be a marker of susceptibility or an intermediate step in the development of metabolic syndrome. However, recently, there have been conflicting conclusions regarding the independent role of uric acid as a risk factor of cardiovascular disease (CVD). The specific role of serum uric acid (SUA) in relation to CVD remains controversial, and there are limited reports utilizing Asian data available on this issue. Therefore, this study investigated the association between SUA and cardiovascular disease in Taiwanese patients with essential hypertension. Methods: There were 3472 participants from 55-80 years of age (1763 males, 1709 females) from 38 sites across Taiwan in this hospital-based cross-sectional study, covering the period November 2005 to December 2006. The CVD included diagnosed angina pectoris, myocardial infarction, congestive heart failure, and stroke. Results: Hyperuricemia is positively associated with CVD in both sexes when a unified cut-off SUA level of 7 mg/dl was used. However, the odds ratios (ORs) for all CVD were greater in magnitude in hypertensive women than in men when there was co-morbidity of diabetes. The ORs of all CVD in the diabetes subgroup were statistically significantly (p = 0.01 for women, p = 0.07 for men). By multivariate analysis, hyperuricemia did not confer an increased risk of CVD. Conclusions: Hyperuricemia may be associated with increased risk of CVD, but is not an independent risk factor of CVD in essential hypertensive Taiwanese patients.
引用
收藏
页码:42 / 51
页数:10
相关论文
共 28 条
[1]   Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us? [J].
Baker, JF ;
Krishnan, E ;
Chen, L ;
Schumacher, HR .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (08) :816-826
[2]   Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study [J].
Chien, KL ;
Hsu, HC ;
Sung, FC ;
Su, TC ;
Chen, MF ;
Lee, YT .
ATHEROSCLEROSIS, 2005, 183 (01) :147-155
[3]  
Chun-Hung S, 2011, ACTA CARDIOL SIN, V27, P229
[4]  
Chung-Sheng L, 2012, INT J CARDIO, V156, P41
[5]   Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study [J].
Culleton, BF ;
Larson, MG ;
Kannel, WB ;
Levy, D .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (01) :7-+
[6]  
Fan X, 2006, CIRCULATION, V114, P492
[7]   Sevum uric acid and cardiovascular mortality - The NHANES I epidemiologic follow-up study, 1971-1992 [J].
Fang, J ;
Alderman, MH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18) :2404-2410
[8]   Allopurinol improves endothelial dysfunction in chronic heart failure [J].
Farquharson, CA ;
Butler, R ;
Hill, A ;
Belch, JJF ;
Struthers, AD .
CIRCULATION, 2002, 106 (02) :221-226
[9]   RELATION OF SERUM URIC-ACID TO MORTALITY AND ISCHEMIC-HEART-DISEASE - THE NHANES-I EPIDEMIOLOGIC FOLLOW-UP-STUDY [J].
FREEDMAN, DS ;
WILLIAMSON, DF ;
GUNTER, EW ;
BYERS, T .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (07) :637-644
[10]   The impact of serum uric acid on cardiovascular outcomes in the LIFE study [J].
Hoieggen, A ;
Alderman, MH ;
Kjeldsen, SE ;
Julius, S ;
Devereux, RB ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristianson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H ;
Chen, C ;
Dahlöf, B .
KIDNEY INTERNATIONAL, 2004, 65 (03) :1041-1049